P21 activated kinase 6: a promising tool for predicting small cell lung cancer diagnosis and treatment response
Serum PAK6 holds significant clinical value for the diagnosis, treatment monitoring, and prognosis evaluation of SCLC and may serve as a potential therapeutic target for the disease.
Authors
- Yinyi Chen
- Liming Tan (ORCID: https://orcid.org/0000-0001-6350-9689)
- Simei Chen
- Xinlu Sun
- Yi Luo (ORCID: https://orcid.org/0000-0001-7051-219X)
- Liping Wei
- Li‐Li Wen (ORCID: https://orcid.org/0000-0003-3013-7289)
- Kexin Han
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Ninth Hospital of Nanchang (CN)
- Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-07-21
- DOI
- https://doi.org/10.7717/peerj.19714
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.05